clinical trials

Over the course of six months, each of the 12 patients accepted into the study received nine infusions of an intravenous immunotherapy drug

By Ask the Doctors • August 8, 2022

Ask the Doctors answers a few of your most-asked questions this month

By Ask the Doctors • June 17, 2022

VALOR trial aims to discover the optimal treatment for stage 1 lung cancer

By Sandy Cohen • May 9, 2022

A UCLA HemOnc Fellow is determined to reduce cancer disparities

By Jocelyn Apodaca Schlossberg • April 25, 2022

When people volunteer to take part in studies, it helps to expand understanding of disease and illness and aids in identifying new avenues of care

By Ask the Doctors • April 18, 2022

Ask the Doctors answers a few of your most-asked questions this month

By Ask the Doctors • March 14, 2022

Berzosertib is one of several repurposed drugs scientists are studying to treat the virus

By uclahealth • November 29, 2021

UCLA researchers are working to decrease illness severity in COVID-19 patients

By uclahealth • November 24, 2020

Researchers have developed a breakthrough in cancer treatment known as chimeric antigen receptor (CAR) T-cell therapy. This promising form of immunotherapy attacks cancerous cells in the body. In 2017, the U.S. Food and Drug Administration (FDA) approved the first CAR T-cell treatments for patients with specific types of leukemia and lymphoma. What is CAR T-cell therapy? Immunotherapy [...]

By uclahealth • October 7, 2019

In 2015, ESPN reporter Holly Row was diagnosed with desmoplastic melanoma, a rare, fast-spreading form of skin cancer. After a first surgery, she enrolled in a UCLA clinical trial led by Dr. Antoni Ribas testing a new approach for advanced melanoma in which participants took the drug Keytruda (pembrolizumab) in [...]

By uclahealth • July 18, 2019